Hovens CM - Search Results

1

Cell quiescence correlates with enhanced glioblastoma cell invasion and cytotoxic resistance.

Atkins RJ, Stylli SS, Kurganovs N, Mangiola S, Nowell CJ, Ware TM, Corcoran NM, Brown DV, Kaye AH, Morokoff A, Luwor RB, Hovens CM, Mantamadiotis T. Atkins RJ, et al. Among authors: hovens cm. Exp Cell Res. 2019 Jan 15;374(2):353-364. doi: 10.1016/j.yexcr.2018.12.010. Epub 2018 Dec 15. Exp Cell Res. 2019. PMID: 30562483

2

The tumour suppressor protein NF2/merlin: the puzzle continues.

Hovens CM, Kaye AH. Hovens CM, et al. J Clin Neurosci. 2001 Jan;8(1):4-7. doi: 10.1054/jocn.2000.0784. J Clin Neurosci. 2001. PMID: 11148074 Review.

3

Genetics of glioblastoma multiforme: mitogenic signaling and cell cycle pathways converge.

Soni D, King JA, Kaye AH, Hovens CM. Soni D, et al. Among authors: hovens cm. J Clin Neurosci. 2005 Jan;12(1):1-5. doi: 10.1016/j.jocn.2004.04.001. J Clin Neurosci. 2005. PMID: 15639402 Review. No abstract available.

4

Distinct requirements for the Sprouty domain for functional activity of Spred proteins.

King JA, Straffon AF, D'Abaco GM, Poon CL, I ST, Smith CM, Buchert M, Corcoran NM, Hall NE, Callus BA, Sarcevic B, Martin D, Lock P, Hovens CM. King JA, et al. Among authors: hovens cm. Biochem J. 2005 Jun 1;388(Pt 2):445-54. doi: 10.1042/BJ20041284. Biochem J. 2005. PMID: 15683364 Free PMC article.

5

Eve-3: a liver enriched suppressor of Ras/MAPK signaling.

King JA, Corcoran NM, D'Abaco GM, Straffon AF, Smith CT, Poon CL, Buchert M, I S, Hall NE, Lock P, Hovens CM. King JA, et al. Among authors: hovens cm. J Hepatol. 2006 Apr;44(4):758-67. doi: 10.1016/j.jhep.2005.10.031. Epub 2005 Dec 12. J Hepatol. 2006. PMID: 16478641

6

Interfering with cell-survival signalling as a treatment strategy for prostate cancer.

Corcoran NM, Costello AJ, Hovens CM. Corcoran NM, et al. Among authors: hovens cm. BJU Int. 2006 Jun;97(6):1149-53. doi: 10.1111/j.1464-410X.2006.06198.x. BJU Int. 2006. PMID: 16686702 Review.

7

Spred-2 steady-state levels are regulated by phosphorylation and Cbl-mediated ubiquitination.

Lock P, I ST, Straffon AF, Schieb H, Hovens CM, Stylli SS. Lock P, et al. Among authors: hovens cm. Biochem Biophys Res Commun. 2006 Dec 29;351(4):1018-23. doi: 10.1016/j.bbrc.2006.10.150. Epub 2006 Nov 3. Biochem Biophys Res Commun. 2006. PMID: 17094949

8

Targeting malignant glioma survival signalling to improve clinical outcomes.

Wong ML, Kaye AH, Hovens CM. Wong ML, et al. Among authors: hovens cm. J Clin Neurosci. 2007 Apr;14(4):301-8. doi: 10.1016/j.jocn.2006.11.005. Epub 2007 Feb 1. J Clin Neurosci. 2007. PMID: 17276069 Review.

9

Expression of ErbB-1 and 2 in vestibular schwannomas.

Wickremesekera A, Hovens CM, Kaye AH. Wickremesekera A, et al. Among authors: hovens cm. J Clin Neurosci. 2007 Dec;14(12):1199-206. doi: 10.1016/j.jocn.2007.05.009. Epub 2007 Oct 26. J Clin Neurosci. 2007. PMID: 17964790

10

Aurora kinase B is an independent protective factor in superficial bladder tumours with a dysfunctional G1 checkpoint.

Bruyere F, Corcoran NM, Berdjis N, Namdarian B, Pedersen J, Ockrim J, Voelzke BB, Costello AJ, Hovens CM. Bruyere F, et al. Among authors: hovens cm. BJU Int. 2008 Jul;102(2):247-52. doi: 10.1111/j.1464-410X.2008.07572.x. Epub 2008 Jul 1. BJU Int. 2008. PMID: 18341621

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

160 results

Search Page